Michael Link

Clinical Focus

• Hematology/Oncology/Stem Cell Transplant, Pediatric
• Pediatric Hematology-Oncology

Administrative Appointments

• Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford (2002 - present)
• Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine (2000 - present)
• Lydia J. Lee Professor in Pediatric Cancer, Stanford University (2003 - present)

Honors and Awards

• Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)
• Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)
• Alpha Omega Alpha, Alpha Omega Alpha (1974)
• Phi Beta Kappa, Phi Beta Kappa (1969)

Professional Education

• Board Certification: General Pediatrics, American Board of Pediatrics (1979)
• Fellowship: Dana-Farber Cancer Institute, MA (1979)
• Fellowship: Children's Hospital of Boston, MA (1979)
• Residency: Children's Hospital of Boston, MA (1976)
• Internship: Children's Hospital of Boston, MA (1975)

Research Interests

Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.

Publications

• Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. Woolf KM, Wei MC, Link MP, Arber DA, Warnke RA "Appl Immunohistochem Mol Morphol" 2008 ; 2 (16) : 196-201
• Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM "J Clin Oncol" 2007 ; 3 (25) : 332-7
• Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. George TI, Jeng M, Berquist W, Cherry AM, Link MP, Arber DA "Pediatr Blood Cancer" 2005 ; 3 (44) : 270-6
• Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H "J Clin Oncol" 2005 ; 9 (23) : 2004-11
• High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC "Cancer" 2004 ; 8 (100) : 1724-33